#BIOSPAIN2023 | The 93.9% of BIOSPAIN 2023 attendees rate the event as 'good' or 'very good' The satisfaction survey highlights significant findings, such as the positive assessment of the program by over 90% of attendees. ➡️ Read more: asebio.com/en/news-events… #WeAreBiotech

#SpainIsBiotech🧬 | In 2021, the #biotechnology sector invested nearly €1.04 billion in R&D, 62% from biotech companies. 64% comes from the companies’ own funds and nearly half goes to pay researchers and technicians. #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | In 2022, the investment secured by Spanish #biotechnology stabilised at €142 million in 46 operations, which is down from the total raised in 2021. #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | #Biotech companies have the most researchers and 60% of all employees are women Biotech companies have the highest percentage of researchers to total employees in the sector: 14.62% of all employees #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech | 4,362 companies carried out #biotechnology activities in 2021, of which 898 are biotech firms. In 2021, the number of companies in the sector grew 11.5% #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | Spanish society increasingly values and is interested in Spanish #science and #technology, and its perception of #innovation compared to other European countries remains the same. #AseBioReport2022 ➡️asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | The #science produced by the Spanish #biotechnology sector is excellent. Spanish #biotechnology makes up 2.6% of global production and is cited 20% more than the global average. #AseBioReport2022 ➡️asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech | The number of partnerships is up nearly 50% in the past five years. Biotech firms forged 295 partnerships and 66% of them were with organisations from the public sector. #AseBioReport2022➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | The impact of new digital technologies is growing #AI and #BigData are the most well-known, applicable and interesting new technologies for companies in the sector, while #biorobotics is ranked last. #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬| The main barrier for #blockchain, #biorobotics and the #IoT in the #biotech sector is lack of awareness, while for #BigData the issue is lack of training and for #AI, the lack of maturity or development #AseBioReport2022➡️asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬| Biotech firms contribute 1% of the GDP and 118,000 jobs. The sector is one of the few to see an increase in production growth, with #biotech firms up 7.8%. #AseBioReport2022 ➡️ asebio.com/en/know-the-se… #WeAreBiotech

#SpainIsBiotech🧬 | Why will 2024 be a key year for biotechnology? The European Commission has highlighted #biotechnology as fundamental for its strategic autonomy ➡️asebio.com/en/actualidad/… #WeAreBiotech

#BIOSPAIN2025 | AseBio - Asociación Española de Bioempresas open the call for expressions of interest for the venue of BIOSPAIN 2025-2029. ➡️ You can find all the information here: asebio.com/actualidad/not…… #WeAreBiotechnology

#AseBioGallery | This is how the 'AseBio Journalism Awards' went organized within the framework of #BIOSPAIN2023 📸 asebio.com/en/news-events… #WeAreBiotechnology

#AseBioID24 | El programa del AseBio Investor Day 2024 incluirá desde la actividad inversora dentro del sector de la #biotecnología en España durante 2023, hasta la investigación de posibles mercados alternativos e instrumentos de financiación #SomosBiotecnología

#AseBioID24 | "AseBio Investor Day es un punto de encuentro único para empresas e inversores del sector #biotecnológico" 📢 Entrevistamos a Susana de Antonio (Susana de Antonio), Head of Listing Spain de Euronext, Silver Sponsor del AseBio Investor Day 2024 asebio.com/actualidad/not…

#AseBioID24 | Inversores nacionales e internacionales de 90 entidades procedentes de 11 países diferentes participarán en una nueva edición del AseBio Investor Day Conoce las claves del evento de la mano de GENESIS Biomed, ASABYS PARTNERS, Inveready y ColumbusVP

BIOSPAIN 2023, finalist in the XIX edition of the Eventoplus Awards for "Best Congress" ➡️You can find all the information here: asebio.com/en/news-events… #WeAreBiotechnology

#BIOSPAIN2023 takes bronze in the “Best Congress” category at the XIX edition of the eventoplus Awards. ➡️You can find all the information here: asebio.com/en/actualidad/… #WeAreBiotechnology